The Conversation asks if subsidising GLP-1s would make Australian care fairer
About half of Australia's roughly 500,000 GLP-1 users pay privately, A$200 to $700 a month, and the authors argue cost hits those with the most obesity hardest.
Recap by typeshit. Full story at The Conversation.